← 產業報告目錄
Codeine Tablet Industry Research Report 2026
出版商 APO Research產業別 Healthcare & Life Sciences出版日期 2026-01-02頁數 131報告編號 APO-86b56e0c7e
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Codeine Tablet market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Codeine Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Codeine Tablet is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Codeine Tablet is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Codeine Tablet include TEVA, Johnson & Johnson, Novartis, Mylan, Taiji, Sanofi Aventis, Pharmaceutical Associates, Medreich and Mallinckrodt, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Codeine Tablet market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Codeine Tablet Market by Company
TEVA
Johnson & Johnson
Novartis
Mylan
Taiji
Sanofi Aventis
Pharmaceutical Associates
Medreich
Mallinckrodt
Lannett Company
Laboratoire Riva
Hikma
Cipla
Aristo Pharma GmbH
Apotex
Codeine Tablet Segment by Type
Single-ingredient Codeine
Multi-ingredient Medications
Codeine Tablet Segment by Application
Narcotic Analgesic
Antitussive
Others
Codeine Tablet Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Codeine Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Codeine Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Codeine Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Codeine Tablet manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Codeine Tablet by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Codeine Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Codeine Tablet Market Size (2021-2032)
2.2.2 Global Codeine Tablet Sales (2021-2032)
2.2.3 Global Codeine Tablet Market Average Price (2021-2032)
2.3 Codeine Tablet by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 Single-ingredient Codeine
2.3.3 Multi-ingredient Medications
2.4 Codeine Tablet by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Narcotic Analgesic
2.4.3 Antitussive
2.4.4 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Codeine Tablet Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Codeine Tablet Sales (K Units) of Manufacturers (2021-2026)
3.3 Global Codeine Tablet Revenue of Manufacturers (2021-2026)
3.4 Global Codeine Tablet Average Price by Manufacturers (2021-2026)
3.5 Global Codeine Tablet Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Codeine Tablet, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Codeine Tablet, Product Type & Application
3.8 Global Manufacturers of Codeine Tablet, Established Date
3.9 Global Codeine Tablet Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 TEVA
4.1.1 TEVA Company Information
4.1.2 TEVA Business Overview
4.1.3 TEVA Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
4.1.4 TEVA Codeine Tablet Product Portfolio
4.1.5 TEVA Recent Developments
4.2 Johnson & Johnson
4.2.1 Johnson & Johnson Company Information
4.2.2 Johnson & Johnson Business Overview
4.2.3 Johnson & Johnson Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
4.2.4 Johnson & Johnson Codeine Tablet Product Portfolio
4.2.5 Johnson & Johnson Recent Developments
4.3 Novartis
4.3.1 Novartis Company Information
4.3.2 Novartis Business Overview
4.3.3 Novartis Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
4.3.4 Novartis Codeine Tablet Product Portfolio
4.3.5 Novartis Recent Developments
4.4 Mylan
4.4.1 Mylan Company Information
4.4.2 Mylan Business Overview
4.4.3 Mylan Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
4.4.4 Mylan Codeine Tablet Product Portfolio
4.4.5 Mylan Recent Developments
4.5 Taiji
4.5.1 Taiji Company Information
4.5.2 Taiji Business Overview
4.5.3 Taiji Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
4.5.4 Taiji Codeine Tablet Product Portfolio
4.5.5 Taiji Recent Developments
4.6 Sanofi Aventis
4.6.1 Sanofi Aventis Company Information
4.6.2 Sanofi Aventis Business Overview
4.6.3 Sanofi Aventis Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
4.6.4 Sanofi Aventis Codeine Tablet Product Portfolio
4.6.5 Sanofi Aventis Recent Developments
4.7 Pharmaceutical Associates
4.7.1 Pharmaceutical Associates Company Information
4.7.2 Pharmaceutical Associates Business Overview
4.7.3 Pharmaceutical Associates Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
4.7.4 Pharmaceutical Associates Codeine Tablet Product Portfolio
4.7.5 Pharmaceutical Associates Recent Developments
4.8 Medreich
4.8.1 Medreich Company Information
4.8.2 Medreich Business Overview
4.8.3 Medreich Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
4.8.4 Medreich Codeine Tablet Product Portfolio
4.8.5 Medreich Recent Developments
4.9 Mallinckrodt
4.9.1 Mallinckrodt Company Information
4.9.2 Mallinckrodt Business Overview
4.9.3 Mallinckrodt Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
4.9.4 Mallinckrodt Codeine Tablet Product Portfolio
4.9.5 Mallinckrodt Recent Developments
4.10 Lannett Company
4.10.1 Lannett Company Company Information
4.10.2 Lannett Company Business Overview
4.10.3 Lannett Company Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
4.10.4 Lannett Company Codeine Tablet Product Portfolio
4.10.5 Lannett Company Recent Developments
4.11 Laboratoire Riva
4.11.1 Laboratoire Riva Company Information
4.11.2 Laboratoire Riva Business Overview
4.11.3 Laboratoire Riva Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
4.11.4 Laboratoire Riva Codeine Tablet Product Portfolio
4.11.5 Laboratoire Riva Recent Developments
4.12 Hikma
4.12.1 Hikma Company Information
4.12.2 Hikma Business Overview
4.12.3 Hikma Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
4.12.4 Hikma Codeine Tablet Product Portfolio
4.12.5 Hikma Recent Developments
4.13 Cipla
4.13.1 Cipla Company Information
4.13.2 Cipla Business Overview
4.13.3 Cipla Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
4.13.4 Cipla Codeine Tablet Product Portfolio
4.13.5 Cipla Recent Developments
4.14 Aristo Pharma GmbH
4.14.1 Aristo Pharma GmbH Company Information
4.14.2 Aristo Pharma GmbH Business Overview
4.14.3 Aristo Pharma GmbH Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
4.14.4 Aristo Pharma GmbH Codeine Tablet Product Portfolio
4.14.5 Aristo Pharma GmbH Recent Developments
4.15 Apotex
4.15.1 Apotex Company Information
4.15.2 Apotex Business Overview
4.15.3 Apotex Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
4.15.4 Apotex Codeine Tablet Product Portfolio
4.15.5 Apotex Recent Developments
5 Global Codeine Tablet Market Scenario by Region
5.1 Global Codeine Tablet Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Codeine Tablet Sales by Region: 2021-2032
5.2.1 Global Codeine Tablet Sales by Region: 2021-2026
5.2.2 Global Codeine Tablet Sales by Region: 2027-2032
5.3 Global Codeine Tablet Revenue by Region: 2021-2032
5.3.1 Global Codeine Tablet Revenue by Region: 2021-2026
5.3.2 Global Codeine Tablet Revenue by Region: 2027-2032
5.4 North America Codeine Tablet Market Facts & Figures by Country
5.4.1 North America Codeine Tablet Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Codeine Tablet Sales by Country (2021-2032)
5.4.3 North America Codeine Tablet Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.5 Europe Codeine Tablet Market Facts & Figures by Country
5.5.1 Europe Codeine Tablet Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Codeine Tablet Sales by Country (2021-2032)
5.5.3 Europe Codeine Tablet Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.5.9 Nordic Countries
5.6 Asia Pacific Codeine Tablet Market Facts & Figures by Country
5.6.1 Asia Pacific Codeine Tablet Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Codeine Tablet Sales by Country (2021-2032)
5.6.3 Asia Pacific Codeine Tablet Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 South America Codeine Tablet Market Facts & Figures by Country
5.7.1 South America Codeine Tablet Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Codeine Tablet Sales by Country (2021-2032)
5.7.3 South America Codeine Tablet Revenue by Country (2021-2032)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Codeine Tablet Market Facts & Figures by Country
5.8.1 Middle East and Africa Codeine Tablet Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Codeine Tablet Sales by Country (2021-2032)
5.8.3 Middle East and Africa Codeine Tablet Revenue by Country (2021-2032)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Codeine Tablet Sales by Type (2021-2032)
6.1.1 Global Codeine Tablet Sales by Type (2021-2032) & (K Units)
6.1.2 Global Codeine Tablet Sales Market Share by Type (2021-2032)
6.2 Global Codeine Tablet Revenue by Type (2021-2032)
6.2.1 Global Codeine Tablet Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Codeine Tablet Revenue Market Share by Type (2021-2032)
6.3 Global Codeine Tablet Price by Type (2021-2032)
7 Segment by Application
7.1 Global Codeine Tablet Sales by Application (2021-2032)
7.1.1 Global Codeine Tablet Sales by Application (2021-2032) & (K Units)
7.1.2 Global Codeine Tablet Sales Market Share by Application (2021-2032)
7.2 Global Codeine Tablet Revenue by Application (2021-2032)
7.2.1 Global Codeine Tablet Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Codeine Tablet Revenue Market Share by Application (2021-2032)
7.3 Global Codeine Tablet Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Codeine Tablet Value Chain Analysis
8.1.1 Codeine Tablet Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Codeine Tablet Production Mode & Process
8.2 Codeine Tablet Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Codeine Tablet Distributors
8.2.3 Codeine Tablet Customers
9 Global Codeine Tablet Analyzing Market Dynamics
9.1 Codeine Tablet Industry Trends
9.2 Codeine Tablet Industry Drivers
9.3 Codeine Tablet Industry Opportunities and Challenges
9.4 Codeine Tablet Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Codeine Tablet Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Codeine Tablet Sales (K Units) of Manufacturers (2021-2026)
Table 7. Global Codeine Tablet Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Codeine Tablet Revenue of Manufacturers (2021-2026)
Table 9. Global Codeine Tablet Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Codeine Tablet Average Price (US$/Unit) of Manufacturers (2021-2026)
Table 11. Global Codeine Tablet Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Codeine Tablet, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Codeine Tablet, Product Type & Application
Table 14. Global Codeine Tablet Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Codeine Tablet by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. TEVA Company Information
Table 19. TEVA Business Overview
Table 20. TEVA Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 21. TEVA Codeine Tablet Product Portfolio
Table 22. TEVA Recent Developments
Table 23. Johnson & Johnson Company Information
Table 24. Johnson & Johnson Business Overview
Table 25. Johnson & Johnson Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 26. Johnson & Johnson Codeine Tablet Product Portfolio
Table 27. Johnson & Johnson Recent Developments
Table 28. Novartis Company Information
Table 29. Novartis Business Overview
Table 30. Novartis Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 31. Novartis Codeine Tablet Product Portfolio
Table 32. Novartis Recent Developments
Table 33. Mylan Company Information
Table 34. Mylan Business Overview
Table 35. Mylan Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 36. Mylan Codeine Tablet Product Portfolio
Table 37. Mylan Recent Developments
Table 38. Taiji Company Information
Table 39. Taiji Business Overview
Table 40. Taiji Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 41. Taiji Codeine Tablet Product Portfolio
Table 42. Taiji Recent Developments
Table 43. Sanofi Aventis Company Information
Table 44. Sanofi Aventis Business Overview
Table 45. Sanofi Aventis Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 46. Sanofi Aventis Codeine Tablet Product Portfolio
Table 47. Sanofi Aventis Recent Developments
Table 48. Pharmaceutical Associates Company Information
Table 49. Pharmaceutical Associates Business Overview
Table 50. Pharmaceutical Associates Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 51. Pharmaceutical Associates Codeine Tablet Product Portfolio
Table 52. Pharmaceutical Associates Recent Developments
Table 53. Medreich Company Information
Table 54. Medreich Business Overview
Table 55. Medreich Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 56. Medreich Codeine Tablet Product Portfolio
Table 57. Medreich Recent Developments
Table 58. Mallinckrodt Company Information
Table 59. Mallinckrodt Business Overview
Table 60. Mallinckrodt Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 61. Mallinckrodt Codeine Tablet Product Portfolio
Table 62. Mallinckrodt Recent Developments
Table 63. Lannett Company Company Information
Table 64. Lannett Company Business Overview
Table 65. Lannett Company Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 66. Lannett Company Codeine Tablet Product Portfolio
Table 67. Lannett Company Recent Developments
Table 68. Laboratoire Riva Company Information
Table 69. Laboratoire Riva Business Overview
Table 70. Laboratoire Riva Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. Laboratoire Riva Codeine Tablet Product Portfolio
Table 72. Laboratoire Riva Recent Developments
Table 73. Hikma Company Information
Table 74. Hikma Business Overview
Table 75. Hikma Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Hikma Codeine Tablet Product Portfolio
Table 77. Hikma Recent Developments
Table 78. Cipla Company Information
Table 79. Cipla Business Overview
Table 80. Cipla Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Cipla Codeine Tablet Product Portfolio
Table 82. Cipla Recent Developments
Table 83. Aristo Pharma GmbH Company Information
Table 84. Aristo Pharma GmbH Business Overview
Table 85. Aristo Pharma GmbH Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Aristo Pharma GmbH Codeine Tablet Product Portfolio
Table 87. Aristo Pharma GmbH Recent Developments
Table 88. Apotex Company Information
Table 89. Apotex Business Overview
Table 90. Apotex Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Apotex Codeine Tablet Product Portfolio
Table 92. Apotex Recent Developments
Table 93. Global Codeine Tablet Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 94. Global Codeine Tablet Sales by Region (2021-2026) & (K Units)
Table 95. Global Codeine Tablet Sales Market Share by Region (2021-2026)
Table 96. Global Codeine Tablet Sales by Region (2027-2032) & (K Units)
Table 97. Global Codeine Tablet Sales Market Share by Region (2027-2032)
Table 98. Global Codeine Tablet Revenue by Region (2021-2026) & (US$ Million)
Table 99. Global Codeine Tablet Revenue Market Share by Region (2021-2026)
Table 100. Global Codeine Tablet Revenue by Region (2027-2032) & (US$ Million)
Table 101. Global Codeine Tablet Revenue Market Share by Region (2027-2032)
Table 102. North America Codeine Tablet Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 103. North America Codeine Tablet Sales by Country (2021-2026) & (K Units)
Table 104. North America Codeine Tablet Sales by Country (2027-2032) & (K Units)
Table 105. North America Codeine Tablet Revenue by Country (2021-2026) & (US$ Million)
Table 106. North America Codeine Tablet Revenue by Country (2027-2032) & (US$ Million)
Table 107. Europe Codeine Tablet Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 108. Europe Codeine Tablet Sales by Country (2021-2026) & (K Units)
Table 109. Europe Codeine Tablet Sales by Country (2027-2032) & (K Units)
Table 110. Europe Codeine Tablet Revenue by Country (2021-2026) & (US$ Million)
Table 111. Europe Codeine Tablet Revenue by Country (2027-2032) & (US$ Million)
Table 112. Asia Pacific Codeine Tablet Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 113. Asia Pacific Codeine Tablet Sales by Country (2021-2026) & (K Units)
Table 114. Asia Pacific Codeine Tablet Sales by Country (2027-2032) & (K Units)
Table 115. Asia Pacific Codeine Tablet Revenue by Country (2021-2026) & (US$ Million)
Table 116. Asia Pacific Codeine Tablet Revenue by Country (2027-2032) & (US$ Million)
Table 117. South America Codeine Tablet Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 118. South America Codeine Tablet Sales by Country (2021-2026) & (K Units)
Table 119. South America Codeine Tablet Sales by Country (2027-2032) & (K Units)
Table 120. South America Codeine Tablet Revenue by Country (2021-2026) & (US$ Million)
Table 121. South America Codeine Tablet Revenue by Country (2027-2032) & (US$ Million)
Table 122. Middle East and Africa Codeine Tablet Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 123. Middle East and Africa Codeine Tablet Sales by Country (2021-2026) & (K Units)
Table 124. Middle East and Africa Codeine Tablet Sales by Country (2027-2032) & (K Units)
Table 125. Middle East and Africa Codeine Tablet Revenue by Country (2021-2026) & (US$ Million)
Table 126. Middle East and Africa Codeine Tablet Revenue by Country (2027-2032) & (US$ Million)
Table 127. Global Codeine Tablet Sales by Type (2021-2026) & (K Units)
Table 128. Global Codeine Tablet Sales by Type (2027-2032) & (K Units)
Table 129. Global Codeine Tablet Sales Market Share by Type (2021-2026)
Table 130. Global Codeine Tablet Sales Market Share by Type (2027-2032)
Table 131. Global Codeine Tablet Revenue by Type (2021-2026) & (US$ Million)
Table 132. Global Codeine Tablet Revenue by Type (2027-2032) & (US$ Million)
Table 133. Global Codeine Tablet Revenue Market Share by Type (2021-2026)
Table 134. Global Codeine Tablet Revenue Market Share by Type (2027-2032)
Table 135. Global Codeine Tablet Price by Type (2021-2026) & (US$/Unit)
Table 136. Global Codeine Tablet Price by Type (2027-2032) & (US$/Unit)
Table 137. Global Codeine Tablet Sales by Application (2021-2026) & (K Units)
Table 138. Global Codeine Tablet Sales by Application (2027-2032) & (K Units)
Table 139. Global Codeine Tablet Sales Market Share by Application (2021-2026)
Table 140. Global Codeine Tablet Sales Market Share by Application (2027-2032)
Table 141. Global Codeine Tablet Revenue by Application (2021-2026) & (US$ Million)
Table 142. Global Codeine Tablet Revenue by Application (2027-2032) & (US$ Million)
Table 143. Global Codeine Tablet Revenue Market Share by Application (2021-2026)
Table 144. Global Codeine Tablet Revenue Market Share by Application (2027-2032)
Table 145. Global Codeine Tablet Price by Application (2021-2026) & (US$/Unit)
Table 146. Global Codeine Tablet Price by Application (2027-2032) & (US$/Unit)
Table 147. Key Raw Materials
Table 148. Raw Materials Key Suppliers
Table 149. Codeine Tablet Distributors List
Table 150. Codeine Tablet Customers List
Table 151. Codeine Tablet Industry Trends
Table 152. Codeine Tablet Industry Drivers
Table 153. Codeine Tablet Industry Restraints
Table 154. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Codeine Tablet Product Image
Figure 5. Global Codeine Tablet Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Codeine Tablet Market Size (2021-2032) & (US$ Million)
Figure 7. Global Codeine Tablet Sales (2021-2032) & (K Units)
Figure 8. Global Codeine Tablet Average Price (US$/Unit) & (2021-2032)
Figure 9. Single-ingredient Codeine Product Image
Figure 10. Multi-ingredient Medications Product Image
Figure 11. Narcotic Analgesic Product Image
Figure 12. Antitussive Product Image
Figure 13. Others Product Image
Figure 14. Global Codeine Tablet Revenue Share by Manufacturers in 2025
Figure 15. Global Manufacturers of Codeine Tablet, Manufacturing Sites & Headquarters
Figure 16. Global Top 5 and 10 Codeine Tablet Players Market Share by Revenue in 2025
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 18. Global Codeine Tablet Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 19. Global Codeine Tablet Sales by Region in 2025
Figure 20. Global Codeine Tablet Revenue by Region in 2025
Figure 21. North America Codeine Tablet Market Size by Country in 2025
Figure 22. North America Codeine Tablet Sales Market Share by Country (2021-2032)
Figure 23. North America Codeine Tablet Revenue Market Share by Country (2021-2032)
Figure 24. United States Codeine Tablet Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 25. Canada Codeine Tablet Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 26. Europe Codeine Tablet Market Size by Country in 2025
Figure 27. Europe Codeine Tablet Sales Market Share by Country (2021-2032)
Figure 28. Europe Codeine Tablet Revenue Market Share by Country (2021-2032)
Figure 29. Germany Codeine Tablet Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 30. France Codeine Tablet Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 31. U.K. Codeine Tablet Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. Italy Codeine Tablet Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. Netherlands Codeine Tablet Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Nordic Countries Codeine Tablet Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Asia Pacific Codeine Tablet Market Size by Country in 2025
Figure 36. Asia Pacific Codeine Tablet Sales Market Share by Country (2021-2032)
Figure 37. Asia Pacific Codeine Tablet Revenue Market Share by Country (2021-2032)
Figure 38. China Codeine Tablet Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Japan Codeine Tablet Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. South Korea Codeine Tablet Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. India Codeine Tablet Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 42. Australia Codeine Tablet Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 43. China Taiwan Codeine Tablet Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. Southeast Asia Codeine Tablet Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. Southeast Asia Codeine Tablet Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. South America Codeine Tablet Market Size by Country in 2025
Figure 47. South America Codeine Tablet Sales Market Share by Country (2021-2032)
Figure 48. South America Codeine Tablet Revenue Market Share by Country (2021-2032)
Figure 49. Mexico Codeine Tablet Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Brazil Codeine Tablet Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. Argentina Codeine Tablet Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. Middle East and Africa Codeine Tablet Market Size by Country in 2025
Figure 53. Middle East and Africa Codeine Tablet Sales Market Share by Country (2021-2032)
Figure 54. Middle East and Africa Codeine Tablet Revenue Market Share by Country (2021-2032)
Figure 55. Turkey Codeine Tablet Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. Saudi Arabia Codeine Tablet Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. UAE Codeine Tablet Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 58. Global Codeine Tablet Sales Market Share by Type (2021-2032)
Figure 59. Global Codeine Tablet Revenue Market Share by Type (2021-2032)
Figure 60. Global Codeine Tablet Price (US$/Unit) by Type (2021-2032)
Figure 61. Global Codeine Tablet Sales Market Share by Application (2021-2032)
Figure 62. Global Codeine Tablet Revenue Market Share by Application (2021-2032)
Figure 63. Global Codeine Tablet Price (US$/Unit) by Application (2021-2032)
Figure 64. Codeine Tablet Value Chain
Figure 65. Codeine Tablet Production Mode & Process
Figure 66. Direct Comparison with Distribution Share
Figure 67. Distributors Profiles
Figure 68. Codeine Tablet Industry Opportunities and Challenges
提及公司
TEVAJohnson & JohnsonNovartisMylanTaijiSanofi AventisPharmaceutical AssociatesMedreichMallinckrodtLannett CompanyLaboratoire RivaHikmaCiplaAristo Pharma GmbHApotex
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們